Document Detail

Silencing of SNX1 by siRNA stimulates the ligand-induced endocytosis of EGFR and increases EGFR phosphorylation in gefitinib-resistant human lung cancer cell lines.
MedLine Citation:
PMID:  22859339     Owner:  NLM     Status:  Publisher    
Gefitinib is known to suppress the activation of EGFR signaling, which is required for cell survival and proliferation in non-small cell lung cancer (NSCLC) cell lines. We previously demonstrated that the gefitinib-sensitive NSCLC cell line PC9 shows efficient ligand-induced endocytosis of phosphorylated EGFR (pEGFR). In contrast, the gefitinib-resistant NSCLC cell lines QG56 and A549 showed internalized pEGFR accumulation in the aggregated early endosomes, and this was associated with SNX1, a protein that interacts with and enhances the degradation of EGFR upon EGF stimulation. In the present study, to investigate the role of SNX1 on EGF-stimulated EGFR/pEGFR endocytosis via the endocytic pathway, we examined the effect of depletion of SNX1 expression by siRNA in human NSCLC cell lines. Using immunofluorescence, we demonstrated that transfection of SNX1 siRNA into gefitinib-resistant NSCLC cells resulted in the disappearance of a large amounts of SNX1 staining. In addition, upon 15 min of EGF stimulation, we observed an efficient EGFR phosphorylation and a rapid endocytic delivery of pEGFR from early endosomes to late endosomes. Further, western blot analysis revealed that silencing of SNX1 expression by siRNA in the gefitinib-resistant cells leads to an accelerated degradation of EGFR along with a dramatic increase in the amounts of pEGFR after EGF stimulation. Based on these findings, we suggest that SNX1 is involved in the negative regulation of ligand-induced EGFR phosphorylation and mediates EGFR/pEGFR trafficking out of early endosomes for targeting to late endosomes/lysosomes via the early/late endocytic pathway in human lung cancer cells.
Yukio Nishimura; Soichi Takiguchi; Kiyoko Yoshioka; Yusaku Nakabeppu; Kazuyuki Itoh
Related Documents :
10537319 - A mammalian severin replaces gelsolin in transformed epithelial cells.
25148579 - Identification of p38 beta as a therapeutic target for the treatment of sézary syndrome.
22879389 - Counteracting autophagy overcomes resistance to everolimus in mantle cell lymphoma.
379979 - Characteristics of individual polymorphonuclear leucocyte motility obtained with a new ...
25453769 - Treatment with udp-glucose, gdnf, and memantine promotes svz and white matter self-repa...
25280969 - Whsc1 promotes oncogenesis through regulation of nima-related-kinase-7 in squamous cell...
14520569 - Extensibility of isolated cell walls in the giant tip-growing cells of the xanthophycea...
9009229 - Rapid internalization of exogenous ganglioside gm3 and its metabolism to ceramide in hu...
21235219 - Chronic exposure to arsenic causes increased cell survival, dna damage, and increased e...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-31
Journal Detail:
Title:  International journal of oncology     Volume:  -     ISSN:  1791-2423     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-8-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Pharmaceutical Cell Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  [Extracorporeal membrane oxygenation and plasmapheresis in the treatment of severe pulmonary hemorrh...
Next Document:  Sample size planning for survival prediction with focus on high-dimensional data.